Somatus
SO
Somatus provides tech-enabled kidney care programs for people with chronic kidney disease and end-stage renal disease. It works with health plans and provider organizations under value-based arrangements. Somatus uses multidisciplinary care teams and analytics to coordinate treatment, support nephrology care, and improve outcomes.
Founded by Ikenna Okezie (CEO, Founder), Anthony Welters (Co-Founder)
Blended valuation$4.2B$4.2B secondary
Valuation history
Weekly blended valuation with priced funding rounds marked on the timeline.
$5.4B
blended valuationfunding round
May 31, 2021$0Oct 5, 2026
All rounds
6 funding rounds, newest first.
| Round | Announced | Raised | Post-money |
|---|---|---|---|
| Series G | Jun 27, 2025 | $300M | $5B |
| Series E | Feb 22, 2022 | $325M | $2.5B |
| Series D | Jun 16, 2021 | $60.1M | $320M |
| Series C | Jun 23, 2020 | $64M | $235.9M |
| Series B | Apr 11, 2018 | $11M | $48.4M |
Join Legion to view all 6 rounds.Sign in to Legion
Investors
16 investors across all rounds.
- DMDeerfield Management
- WMWellington Management
- FIFidelity
- GIGIC
- LCLongitude Capital
- OVOptum Ventures
- RCRA Capital Management
- THTown Hall Ventures
- FCFlare Capital Partners
- BBBlueCross BlueShield Venture Partners
Only Legion members can view the full investor roster. Sign in to Legion
Secondary market activity
Recent buy and sell interest for Somatus shares on the secondary market.
| Kind | Implied valuation | Price / share | Date |
|---|---|---|---|
| $4.9B | — | Oct 6, 2026 | |
| $2.8B | $962.05 | Aug 26, 2026 | |
| $2.5B | $861.88 | Jul 24, 2026 |
Invest in the private markets on Legion
Registered users see full trading activity, every investor, rankings, and live deals.
Data as of Oct 16, 2026. Valuations are estimates blended from primary and secondary-market signals — not investment advice.